As expected, the ID-1 antibody inhibited the cell viability and induced cell lysis more efficiently in the IgG1 isotype due to its ability to induce ADCC, not shared by IgG4, which seems to be essential for the full anti-tumor activity of the anti-CTLA-4 mAb. This evidence concerns the gene CTLA4 and neoplasm.